Table 2_A pharmacovigilance study of Bruton’s tyrosine kinase inhibitors: a multidimensional analysis based on FAERS and VigiBase.xlsx
Introduction<p>The safety concerns of Bruton's tyrosine kinase inhibitors (BTKis) have garnered significant attention due to their severe adverse reactions. However, no existing studies have utilized VigiBase, the world's largest adverse event reporting system, to conduct post-market...
Bewaard in:
| Hoofdauteur: | Han Qu (4391905) (author) |
|---|---|
| Andere auteurs: | Yuqi Jia (12074459) (author), Zizhen Liu (10067249) (author), Zuan Li (13285615) (author), Xin Zhao (71840) (author), Zhenghua Wu (548294) (author), Guorong Fan (2294386) (author), Yuefen Lou (11843792) (author) |
| Gepubliceerd in: |
2025
|
| Onderwerpen: | |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|
Gelijkaardige items
-
Table 1_A pharmacovigilance study of Bruton’s tyrosine kinase inhibitors: a multidimensional analysis based on FAERS and VigiBase.docx
door: Han Qu (4391905)
Gepubliceerd in: (2025) -
Table 3_Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases.xlsx
door: Satoko Watanabe (59124)
Gepubliceerd in: (2025) -
Table 2_Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases.xlsx
door: Satoko Watanabe (59124)
Gepubliceerd in: (2025) -
Table 4_Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases.xlsx
door: Satoko Watanabe (59124)
Gepubliceerd in: (2025) -
Table 1_Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases.xlsx
door: Satoko Watanabe (59124)
Gepubliceerd in: (2025)